CryoLife, Inc. (CRY) Reports In-Line Q3 EPS, Offers Insight on FY11 Outlook
Tweet
Share
E-mailGet Alerts CRY Hot Sheet
Join SI Premium – FREE
CryoLife, Inc. (NYSE: CRY) reported Q3 adjusted EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $29.7 million versus the consensus estimate of $30.64 million.
CryoLife, Inc. sees FY2011 EPS of $0.32-$0.34, versus the consensus of $0.38. The Company expects total revenues for the full year of 2011 to be slightly below the lower end of its range of between $122.0 million and $125.0 million.
CryoLife, Inc. sees FY2011 EPS of $0.32-$0.34, versus the consensus of $0.38. The Company expects total revenues for the full year of 2011 to be slightly below the lower end of its range of between $122.0 million and $125.0 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
- AIRO Group Holdings, Inc. (AIRO) Reports Q2 Loss of $0.06
- Pluralsight (PS) Reports Q2 EPS of $0.14
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
